← Back to Search

Behavioural Intervention

SCGC + Parent/Clinician Interventions for Autism

N/A
Waitlist Available
Led By Nathan Call, PhD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9, 12, 16, 21, and 30 months of age
Awards & highlights

Study Summary

This trial is designed to find the most effective, cost-efficient treatment for young children with Autism Spectrum Disorder by comparing different parent and child interventions.

Who is the study for?
This trial is for infants with a sibling in the Emory Autism Center of Excellence, showing early signs of autism. It's especially for those who didn't respond to initial interventions and are identified by specific autism screening tools.Check my eligibility
What is being tested?
The study tests two approaches: web-based parent education on social communication (SCGC) versus usual care, followed by comparing a parent-implemented or clinician-implemented intervention if early signs of ASD persist.See study design
What are the potential side effects?
Since this trial involves educational and behavioral interventions rather than medications, there are no typical drug side effects; however, participation may involve time commitment and emotional impact.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9, 12, 16, 21, and 30 months of age
This trial's timeline: 3 weeks for screening, Varies for treatment, and 9, 12, 16, 21, and 30 months of age for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Autism Diagnostic Observation Schedule Score
Change in Autism Diagnostic Observation Schedule Score in Children Showing Signs of ASD
Change in Communication and Symbolic Behavior Scales (CSBS) Score
+7 more

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Social Communication Growth Charts (SCGC)Experimental Treatment1 Intervention
Infants with a sibling who is diagnosed with ASD, who are randomized to receive the Social Communication Growth Charts (SCGC) intervention.
Group II: Parent-Implemented (P-I) ConditionExperimental Treatment1 Intervention
Participants showing early signs of ASD at 12 months of age, randomized to receive a parent-implemented (P-I) condition of a naturalistic developmental behavioral intervention (NDBI) based on the Early Social Interaction model.
Group III: Clinician-Implemented (C-I) ConditionExperimental Treatment1 Intervention
Participants showing early signs of ASD at 12 months of age, randomized to receive a clinician-implemented (C-I) condition NDBI based on a hybrid model.
Group IV: Usual careActive Control1 Intervention
Infants with a sibling who is diagnosed with ASD, who are randomized to receive usual care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Clinician-Implemented (C-I) Condition
2018
N/A
~270
Social Communication Growth Charts (SCGC)
2018
N/A
~270
Parent-Implemented (P-I) Condition
2018
N/A
~270

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,642 Previous Clinical Trials
2,563,633 Total Patients Enrolled
23 Trials studying Autism Spectrum Disorder
21,318 Patients Enrolled for Autism Spectrum Disorder
National Institute of Mental Health (NIMH)NIH
2,789 Previous Clinical Trials
2,690,161 Total Patients Enrolled
81 Trials studying Autism Spectrum Disorder
40,083 Patients Enrolled for Autism Spectrum Disorder
Nathan Call, PhDPrincipal InvestigatorEmory University
4 Previous Clinical Trials
196 Total Patients Enrolled
4 Trials studying Autism Spectrum Disorder
196 Patients Enrolled for Autism Spectrum Disorder

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research initiative currently accepting new participants?

"As per the information on clinicaltrials.gov, this medical trial is presently enrolling patients. This project was initiated on February 1st 2018 and has since been updated as of September 22nd 2022."

Answered by AI

How many participants are accepted into this medical experiment?

"Affirmative. According to the clinicaltrials.gov repository, this research protocol is open for enrollment with a starting date of February 1st 2018 and an updated posting on September 22nd 2022. 300 individuals will be accepted from one medical site."

Answered by AI

Is eligibility to join this trial open to me?

"This clinical trial is recruiting 300 participants, aged between 6 and 24 months, who have been diagnosed with autism spectrum disorder. In addition to this condition, they must also meet the following criteria: having an ASD sibling enrolled in the Emory Autism Center of Excellence; not responding to Stage 1 intervention (non-responders being infants displaying early signs of communication delay); exhibiting initial indications of ASD attested by a positive score on the Infant-Toddler Checklist (ITC) plus at least two results from either Early Screening for Autism and Communication Disorders (ESAC), Systematic Observation of Red Flags of ASD Clinic or SOR"

Answered by AI

Is the recruitment process for this trial open to those aged 70 and above?

"According to the eligibility criteria for this study, infants aged 6 months old are eligible to participate and no upper age limit has been set."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Promoting Transactional Supports to Optimize Social Communication Outcomes for Infants and Their Families
Nathan A. Call 2018. "Promoting Transactional Supports to Optimize Social Communication Outcomes for Infants and Their Families". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03307057.
~37 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top